Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Junta de Andalucía, Ministerio de Ciencia e Innovación Background Bicuspid aortic valve (BAV) is the most common congenital cardiac malformation. It predisposes to thoracic aortic dilatation (TAD), aneurysm and dissection. The current consensus is that the genetic defect that leads to the aortic valve malformation also causes structural anomalies of the ascending aorta. Altered hemodynamics caused by the abnormal valve morphology would accelerate aortic media degeneration. Molecular markers and pathways involved in the aetiology and pathophysiology of bicuspid aortopathy are poorly understood. Objective To elucidate the molecular and cellular mechanisms of the disease and to identify potential predictive molecular markers using a well-established isogenic hamster model (T strain) with a high (∼40%) incidence of BAV TAD. Methods Comparative quantitative proteomics combined with Western blot and morpho-molecular analyses in the ascending aorta of tricuspid aortic valve (TAV) and BAV animals from the T strain and TAV animals from a control strain. This strategy allows exploring independently the genetic and hemodynamic effects on the aorta in genetically homogeneous populations. Results The major molecular defect in the aorta of genetically homogeneous BAV individuals is PI3K/AKT overactivation caused by alterations in the EGF, ANGII and TGF-β signalling pathways. PI3K/AKT affects the downstream eNOS, MAP2K1/2, NF-κB, mTOR and WNT pathways. Most of these alterations are seen in independent patient studies with different clinical presentations, but not in TAV hamsters from the T strain, which mainly show downregulation of the WNT pathway. Conclusions We identify a combination of defective interconnected molecular pathways, directly linked to the central PI3K/AKT pathway, common to both BAV-associated TAD patients and hamsters. The defects indicate a shift of smooth muscle cells towards the synthetic phenotype induced by endothelial-to-mesenchymal transition, oxidative stress and inflammation. WNT signalling represents a genetic factor that may cause aortic structural abnormalities and aneurysm predisposition, whereas hemodynamics is the main trigger of molecular changes, likely determining the progression of aortopathy. We identify twenty-seven novel potential biomarkers with high predictive value.

RCN is seeking consistency in national standards.

Pathophysiology of aortic aneurysm: insights from human genetics and mouse models

Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models

Cellular Mechanisms of Aortic Aneurysm Formation

Cellular signaling in Abdominal Aortic Aneurysm

Inflammation in thoracic aortic aneurysms

Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm

Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression

Animal Models, Pathogenesis, and Potential Treatment of Thoracic Aortic Aneurysm

Altered Transforming Growth Factor-Beta Signaling in a Murine Model of Thoracic Aortic Aneurysm

University of Groningen Periodontitis Prevalence and Severity in Indonesians With Type 2 Diabetes

The mechanism and therapy of aortic aneurysms

Using Molecular Targets to Predict and Treat Aortic Aneurysms.

Matricellular Proteins: Potential Biomarkers and Mechanistic Factors in Aortic Aneurysms.

Cutaneous side‐effects of transdermal iontophoresis with and without surfactant pretreatment: a single‐blinded, randomized controlled trial

Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections

Non‐syndromic thoracic aortic aneurysm: cellular and molecular insights

Connecting the dots: molecular pathways in bicuspid aortopathy explored

Progress on the Role of Vascular Endothelial Cells in the Formation of Aortic Aneurysms

Unraveling the Role of TGFβ Signaling in Thoracic Aortic Aneurysm and Dissection Using Fbn1 Mutant Mouse Models

Molecular targets in aortic aneurysm for establishing novel management paradigms